Global Health Limited

NSE: MEDANTA
ISIN: INE474Q01031
Segment: Mainboard

Open on desktop to take part.

Community opinion on stories about MEDANTA, last 7 days: No votes on recent stories yet.

What users voted on these stories. Not Bazaar Updates's assessment, and not advice.

News

All event types

Free plan: one type at a time. Paid combines several.

ResultsBoard outcomeBoard meeting dateDividendCorporate actionFundraiseM&AOrder / contractPledgeInsider / SASTRatingManagement changeRegulatoryLitigationInvestor communicationShareholder meetingTrading windowRoutine complianceMarket-wideOther

Press ? for shortcuts

9 Oct
Fortis Healthcare, Apollo Hospitals, Max, Medanta shares rise: Should investors buy after 30% cancer drug price cap?
Livemint Markets
MAXHEALTH FORTIS APOLLOHOSP MEDANTA
9 Oct
Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullish
The Economic Times Stocks2 sources
MAXHEALTH FORTIS APOLLOHOSP MANIPALHOS MEDANTA

You've seen all available stories from the last 3 days included in the free plan. Get 10 days with a trial or 30 days with a paid plan.

Report

Fortis Healthcare, Apollo Hospitals, Max, Medanta shares rise: Should investors buy after 30% cancer drug price cap? ↗

Livemint Markets · 9 Oct, 12:49 IST

Hospital stocks rallied after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially cutting prices by 20–70% and saving patients ₹2,500 crore annually. Brokerages said earnings effects may be manageable but warned that hospital margins could face pressure.
From Livemint Markets

Read full story ↗

Open on desktop to take part.

0 comments

Comments are posted by users and are not reviewed by Bazaar Updates.

Open on desktop to take part.

No comments yet.

Stories link to their original sources. Vote counts and comments are user opinion, not Bazaar Updates's assessment, and not investment advice.

Plans Terms Privacy Source status Grievances